U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364851) titled 'A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers' on Jan. 06.
Brief Summary: Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1
Study Start Date: March 06
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Volunteer
Intervention:
DRUG: DW4421-T1
DW4421-T1 or DW4421S-T1
DRUG: DW4421S-T1
DW4421-T1 or DW4421S-T1
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daewon Pharmaceutical Co., Ltd.
Disclaimer: Curated by HT Syndication....